A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Sulfapyridine
Dactylis glomerata pollen
The risk or severity of adverse effects can be increased when Spirapril is combined with Dactylis glomerata pollen.
Sulfapyridine
Festuca pratensis pollen
The risk or severity of adverse effects can be increased when Spirapril is combined with Festuca pratensis pollen.
Sulfapyridine
Poa pratensis pollen
The risk or severity of adverse effects can be increased when Spirapril is combined with Poa pratensis pollen.
Sulfapyridine
Sorghum halepense pollen
The risk or severity of adverse effects can be increased when Spirapril is combined with Sorghum halepense pollen.
Sulfapyridine
Poa annua pollen
The risk or severity of adverse effects can be increased when Spirapril is combined with Poa annua pollen.
Sulfapyridine
Sodium phosphate, monobasic
The risk or severity of nephrotoxicity can be increased when Spirapril is combined with Sodium phosphate, monobasic.
Sulfapyridine
Lanthanum carbonate
Lanthanum carbonate can cause a decrease in the absorption of Spirapril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sulfapyridine
Dexniguldipine
The risk or severity of hyperkalemia can be increased when Spirapril is combined with Dexniguldipine.
Sulfapyridine
Tetrandrine
The risk or severity of hyperkalemia can be increased when Spirapril is combined with Tetrandrine.
Sulfapyridine
Lomerizine
The risk or severity of hyperkalemia can be increased when Spirapril is combined with Lomerizine.
Sulfapyridine
Emopamil
The risk or severity of hyperkalemia can be increased when Spirapril is combined with Emopamil.
Sulfapyridine
Dexverapamil
The risk or severity of hyperkalemia can be increased when Spirapril is combined with Dexverapamil.
Sulfapyridine
Fish oil
The risk or severity of hyperkalemia can be increased when Spirapril is combined with Fish oil.
Sulfapyridine
WIN 55212-2
The risk or severity of hyperkalemia can be increased when Spirapril is combined with WIN 55212-2.
Sulfapyridine
Caroverine
The risk or severity of hyperkalemia can be increased when Spirapril is combined with Caroverine.
Sulfapyridine
Penfluridol
The risk or severity of hyperkalemia can be increased when Spirapril is combined with Penfluridol.
Sulfapyridine
Tertatolol
The risk or severity of hyperkalemia can be increased when Spirapril is combined with Tertatolol.
Sulfapyridine
Lidoflazine
The risk or severity of hyperkalemia can be increased when Spirapril is combined with Lidoflazine.
Sulfapyridine
Epanolol
The risk or severity of hyperkalemia can be increased when Spirapril is combined with Epanolol.
Sulfapyridine
Terodiline
The risk or severity of hyperkalemia can be increased when Spirapril is combined with Terodiline.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3